StockDrifts LogoStockDrifts

Leeyeon Pharmaceutical 102460

Company
이연제약Leeyeon Pharmaceutical
Insiders
1
Buys
0
Total Value
₩422M ($293K)
Avg Return
+22.58%
Last Filing
2025-02-26

Leeyeon Pharmaceutical (102460) has 0 disclosed insider purchases and 4 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩422M ($293K) in reported transaction value. The earliest filing StockDrifts holds for Leeyeon Pharmaceutical is dated 2024-02-21; the most recent is 2025-02-26. Across these filings the average return since disclosure is +22.58%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-02-26SELL시간외매매
정순옥
Soonok Jeong
CEO Chairman-129.9K₩12,690+7.7%₩1.6B ($1.1M)
2024-02-26SELLMarket Sell
정순옥
Soonok Jeong
CEO Chairman-3.0K₩14,930+21.6%₩45M ($31K)
2024-02-23SELLMarket Sell
정순옥
Soonok Jeong
CEO Chairman-4.3K₩15,030+22.1%₩65M ($45K)
2024-02-22SELLMarket Sell
정순옥
Soonok Jeong
CEO Chairman-12.0K₩15,100+22.4%₩181M ($126K)
2024-02-21SELLMarket Sell
정순옥
Soonok Jeong
CEO Chairman-8.5K₩15,450+24.2%₩131M ($91K)

Frequently asked questions

Who has been buying Leeyeon Pharmaceutical stock?
1 distinct insiders have filed 0 disclosed insider purchases in Leeyeon Pharmaceutical (102460), most recently on 2025-02-26. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Leeyeon Pharmaceutical have?
Leeyeon Pharmaceutical has 0 buy-side and 4 sell-side disclosures on record, covering ₩422M ($293K) in total reported value, spanning 2024-02-21 to 2025-02-26.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.